QUFU, CHINA--(MARKET WIRE)--Mar 11,
2009 -- Sunwin International
Neutraceuticals, Inc. (OTC BB:
SUWN.OB
-
News), one of the world's
leading producers of all natural,
zero calorie stevia, announced today
the company has recently received a
purchase order from Beijing
Tongrentang Technologies Co., Ltd.
("Tongrentang"), the world's largest
producer of traditional Chinese
medicine, to develop a new dietary
supplement product for diabetic
patients.
Tongrentang is a Chinese
pharmaceutical company founded in
1669 by a senior physician of the
royal court of the Qing Dynasty. The
company generated approximately $165
million revenue in fiscal 2007.
Today Tongrentang is the largest and
one of the oldest producers of
traditional Chinese medicine.
Stevia provides consumers a
zero-calorie all natural sweetener
alternatives to chemical-based
sweeteners commonly utilized in diet
or low calorie products. Sunwin's
stevia production has been used
around the world for decades, today
Sunwin's proprietary brand OnlySweet
is being sold in the U.S. and is
found in approximately 4,000 retail
stores.
Sunwin's Chairman Laiwang Zhang
commented, "We are extremely excited
about this purchase order from
Tongrentang for the development of
this new dietary supplement. When
completed this represents another
large market opportunity for the use
of our stevia applications.
Moreover, our relationship with
Tongrentang demonstrates the quality
of our stevia product for use by
multinational companies."
Company Background:
Sunwin International
Neutraceuticals, Inc. engages in the
areas of essential traditional
Chinese medicine, zero calorie
natural sweeteners (stevia), and
veterinary medicines and feeds
prepared from 100 percent organic
herbal ingredients. As an industry
leader in agricultural processing,
Sunwin has built an integrated
global firm with the sourcing and
production capabilities to meet the
needs of consumers throughout the
world. Sunwin also makes such
value-added products as specialty
veterinary food ingredients and
specialty feed ingredients. For more
info about Sunwin, please visit
http://www.sunwininternational.com
Safe Harbor Statement
In connection with the safe
harbor provisions of the Private
Securities Litigation Reform Act of
1995, Sunwin International
Neutraceuticals, Inc., is hereby
providing cautionary statements
identifying important factors that
could cause our actual results to
differ materially from those
projected in forward-looking
statements (as defined in such act).
Any statements that are not
historical facts and that express,
or involve discussions as to,
expectations, beliefs, plans,
objectives, assumptions or future
events or performance (often, but
not always, indicated through the
use of words or phrases such as
"will likely result," "are expected
to," "will continue," "is
anticipated," "estimated,"
"intends," "plans," "believes" and
"projects") may be forward-looking
and may involve estimates and
uncertainties which could cause
actual results to differ materially
from those expressed in the
forward-looking statements.
These statements include, but are
not limited to, our ability to
develop the new dietary supplement
for Tongrentang, the size of the
expected market for this stevia
application and the quality of our
stevia products as stated above. We
caution that the factors described
herein could cause actual results to
differ materially from those
expressed in any forward-looking
statements we make and that
investors should not place undue
reliance on any such forward-looking
statements. Further, any
forward-looking statement speaks
only as of the date on which such
statement is made, and we undertake
no obligation to update any
forward-looking statement to reflect
events or circumstances after the
date on which such statement is made
or to reflect the occurrence of
anticipated or unanticipated events
or circumstances. New factors emerge
from time to time, and it is not
possible for us to predict all of
such factors. Further, we cannot
assess the impact of each such
factor on our results of operations
or the extent to which any factor,
or combination of factors, may cause
actual results to differ materially
from those contained in any
forward-looking statements. This
press release is qualified in its
entirety by the cautionary
statements and risk factor
disclosure contained in our
Securities and Exchange Commission
filings, including our Annual Report
on Form 10-K for the fiscal year
ended April 30, 2008 and our reports
on Form 10-Q.